Exp Clin Endocrinol Diabetes 2001; 109(Suppl 2): S215-S224
DOI: 10.1055/s-2001-18583
Physiology - Metabolism - Pathophysiology

© Johann Ambrosius Barth

Obesity: causes and new treatments

P. J. Lefèbvre, A. J. Scheen
  • Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, University of Liège, Belgium
Further Information

Publication History

Publication Date:
23 November 2001 (online)

Summary:

The prevalence of obesity increases rapidly in developed and developing countries. Obesity results from a cumulative positive energy balance and is favoured by both genetic and environmental factors. Preventing obesity requires a major investment in nutritional and lifestyle education, particularly in children and adolescents. - The pharmacological approach to obesity includes drugs that reduce food intake (noradrenergic and serotoninergic agents), drugs that increase energy expenditure and compounds that affect nutrient partitioning. In all instances, the benefit-to-risk ratio needs to be carefully assessed. In some patients (severe obesity or obesity accompanied by serious high-risk comorbid conditions), gastric surgery (gastric restriction or gastric bypass) should be considered. In our own experience, it is safe and effective.

    >